Stoke Therapeutics, Inc. (STOK) SEC Filings — 2025
13 SEC filings for Stoke Therapeutics, Inc. (STOK) in 2025.
Filings
- Stoke Therapeutics Files 8-K — 8-K · Dec 5, 2025
- Stoke Swings to Profit on Revenue Surge, Q3 Loss Widens — 10-Q · Nov 4, 2025
- Stoke Therapeutics Files 8-K on Officer/Director Changes — 8-K · Oct 6, 2025
- Stoke Therapeutics Files 8-K/A Amendment — 8-K/A · Sep 18, 2025
- Stoke's Q2 Losses Widen Amid Increased R&D Spend — 10-Q · Aug 12, 2025
- Stoke Therapeutics Files 8-K — 8-K · Aug 11, 2025
- Stoke Therapeutics Files 8-K — 8-K · Jul 10, 2025
- Stoke Therapeutics Files 8-K Report — 8-K · Jun 4, 2025
- Stoke Therapeutics Files Q1 2025 10-Q — 10-Q · May 13, 2025
- Stoke Therapeutics Files 2025 Proxy Statement — DEF 14A · Apr 22, 2025
- Stoke Therapeutics Files 2024 10-K — 10-K · Mar 18, 2025
- Stoke Therapeutics Files 8-K with Material Agreement — 8-K · Feb 18, 2025
- Stoke Therapeutics Files 8-K Report — 8-K · Jan 7, 2025